Загрузка...
Population Pharmacokinetics and Safety of Piperacillin-Tazobactam Extended Infusions in Infants and Children
Piperacillin-tazobactam (TZP) is frequently used to treat severe hospital-acquired infections in children. We performed a single-center, pharmacokinetic (PK) trial of TZP in children ranging in age from 2 months to 6 years from various clinical subpopulations. Children who were on TZP per the standa...
Сохранить в:
| Опубликовано в: : | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811421/ https://ncbi.nlm.nih.gov/pubmed/31427292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01260-19 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|